Fulgent Genetics (FLGT) Price to Earnings (2016 - 2026)

Fulgent Genetics has disclosed Price to Earnings across 11 years of filings, most recently posting 19.12 for Q2 2026.

• In Q2 2026, Price to Earnings rose 40.43% year-over-year to 19.12; the TTM figure through Jun 2026 stood at 6.69 (up 43.89% YoY), while the FY2025 annual figure was 13.49, down 1.16% from the prior year.
• Price to Earnings came in at 19.12 for Q2 2026 at Fulgent Genetics, down from 18.48 in the prior quarter.
• In the past five years, Price to Earnings ranged from a high of 842.47 in Q3 2022 to a low of 105.52 in Q3 2025.
• Average Price to Earnings over 5 years is 12.63, with a median of 40.65 recorded in 2022.
• Year-over-year, Price to Earnings jumped 3737.71% in 2022 and slumped 1346.19% in 2024.
• Over 5 years, Price to Earnings stood at 36.41 in 2022, then soared by 81.63% to 6.69 in 2023, then tumbled by 1346.19% to 96.74 in 2024, then surged by 63.96% to 34.87 in 2025, then jumped by 45.16% to 19.12 in 2026.
• Per Business Quant data, the three most recent Price to Earnings figures were 19.12 in Q2 2026, 18.48 in Q1 2026, and 34.87 in Q4 2025.